Beyond semaglutide and tirzepatide, where might we find the next GLP 1 based advances in #weightloss #obesity Take a look at the slope of the lines for the combination of cagrilintide + semaglutide and Retatrutide, Retatrutide vs. Tirzepatide, Retatrutide vs. Semaglutide, Retatrutide vs. Cagrilintide Cagrilintide: What It Is and How It's Being Studied for Weight Loss Tirzepatide: a new low for bodyweight and blood glucose The Lancet Diabetes & Endocrinology What is the pipeline for future medications for obesity? International Journal of Obesity Tirzepatide, a dual GIP GLP 1 receptor co agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction Cardiovascular Diabetology Springer Nature Link